• 尊龙凯时AG(中国区)官方网站

    Contact Online
    China Sales Center
    Tel: +8657689189675
    Email: tianyu@rkysy.com
    Latin America Market
    Tel: 0576-89189685
    Email: ok@rkysy.com
    Europe & North America Market
    Tel: 0576-89189306
    Email: hhy@rkysy.com
    Row Market(CIS、Turkey、Africa、etc.)
    Tel: 0576-89189688
    Email: pb@rkysy.com
    Securities Investment dept.
    Tel: +8657689189669
    Email: stock@rkysy.com
    HR dept.
    Tel: +8657684160783
    Email: job@rkysy.com
    Purchasing dept.
    Tel: +8657689189703
    Email: wyj@rkysy.com
    Tianyu Shares
    R&D information
    ●Tianyu has following 3 R&D centers with total of more than 180 chemists.
      Hangzhou R&D center,Taizhou R&D center ,and Shanghai R&D center.
    ● The company has 12 national invention patents and 2 PCT patents (US, Canada) up to the present.
    RESEARCH & DEVELOPMENT
    Tianyu Pharmaceutical emphasizes the continuous research and development of new products and new processes. Through many years of investment and development, it has attained a strong R&D capability. While building our brand's core competiveness, we have built a professional R&D team consisting of over 150 chemists with a good number of PhD and Master degrees, who inject infinite vitality into the R&D activities of Tianyu, They have become the strong driving forces of the development of our company.
    Tianyu has built three R&D centers, realized a systematic research platform and established industry leadership in the level of R&D excellence. It has obtained the synthesis patents of API like Valsartan,Ezetimibe,Telmisartan and Aliskiren, and won multiple provincial- and municipal-class technology and development prizes.